← FDA Drug Approvals (Drugs@FDA)

CAPITAL SOLEIL 15

NDA · New Drug Application · Sponsor: LOREAL USA · Approved 2006-10-02

Drug application

FDA Application #

NDA021501

Application type

New Drug Application

Brand name

CAPITAL SOLEIL 15

Generic name

Avobenzone

Active ingredients

AVOBENZONE; ECAMSULE; OCTOCRYLENE

Dosage form

CREAM

Route

TOPICAL

Marketing status

Over-the-counter

Sponsor

LOREAL USA

First approval

2006-10-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown